SinglePoint (OTCQB: SING) today announced the launch of Klen Hands. Customers can subscribe and preorder now, and shipments are expected to leave the company’s Carlsbad facility in approximately 10 business days. There is a limited supply, which the company anticipates will sell out quickly. The hand sanitizer has 62% ethyl alcohol to keep hands “klen” (clean), as well as hemp seed oil to keep hands soft and hydrated. “We are working to develop solutions for both product and technology in order to assist in the effort of combating COVID-19. As many people know our company has deep ties to the Washington State area. We believe we can provide solutions in the near term to help with the dissemination of current, reliable information and in the interim use our facilities to develop products such as hand sanitizer. We will be releasing additional resources for individuals in the coming weeks,” SING CEO Greg Lambrecht stated in the news release.

To view the full press release, visit http://cnw.fm/fN1ZQ

About SinglePoint Inc.

Founded in 2011, SinglePoint invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multinational brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. Among other highlights from this week’s program, SinglePoint CEO Greg Lambrecht discussed a successful NYC trip. “As a lot of the shareholders know, this is going to be two years now that SinglePoint is fully reporting and, as discussed before, it looks like we’re going to show revenues of $3.3 million,” Lambrecht said during the program. “In going to New York this time, we were able to get five or six meetings with mid-tier investment groups, and they’re very interested in SinglePoint and taking us to the next exchange, whether that’s the Nasdaq or the New York Stock Exchange.”

To view the full press release, visit http://cnw.fm/Z4Pob

About SinglePoint Inc.

Founded in 2011, SinglePoint invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multinational brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Eight Pennsylvania universities are launching marijuana studies in collaboration with marijuana producers. Kent Vrana, who is a researcher at Penn State, said that since the research is being partially funded by the medical marijuana industry, the program is unique.

Vrana further said that the Commonwealth of Pennsylvania is using tax dollars to fund the research. Vrana serves as the chairman of the department of pharmacology at Penn State College of Medicine, which is based in Hershey.

Although marijuana is legal in both medical and recreational forms in many states, Pennsylvania’s medical marijuana law also includes the research program. Vrana is optimistic that good things will emerge from the research program.

Each of the eight research programs is supposed to enter into a contract with a marijuana producer, grower, and processor, as well as own a dispensary license. The cannabis producer is referred to as a clinical registrant as per the law.

Below are some of the collaborations between the universities and clinical registrants:

• Drexel University College of Medicine contracted Agronomed Biologics LLC.
• Lewis Katz School of Medicine at Temple University contracted Laurel Harvest Labs LLC.
• Penn State College of Medicine contracted PA Options for Wellness Inc.
• Sidney Kimmel Medical College at Thomas Jefferson University contracted MLH Explorations LLC.
• The Perelman School of Medicine at the University of Pennsylvania contracted Curaleaf PA LLC.
• Lake Erie College of Osteopathic Medicine contracted CannTech PA LLC
• Philadelphia College of Osteopathic Medicine is working with Organic Remedies Inc.

The University Of Pittsburgh School Of Medicine is the eighth research program, and its proposed clinical registrant was not approved by the state, although its application would be resubmitted under an extended deadline within which they are required to meet the additional requirement to qualify as their partner.

The Health Department announced that all the eight medical schools and the marijuana companies would meet in March to finalize their research plans.

Penn State research would be about developing a database that would assist in comparing responses among patients whose medical ailments improved because of marijuana consumption while its partner clinical registrant, PA Options for Wellness Inc., would be conducting double-blind clinical trials under the supervision of experts at Hershey’s medical school, Vrana said.

Vrana further said that the double-blind clinical trials are the scientific gold standard. The patients who will be volunteering for the clinical trial would be divided into two groups, with one group receiving marijuana while the other group would be given an inert compound, referred to as a placebo. Only the physician can identify the patients receiving medical marijuana.

The study will then compare the responses and symptoms of patients in both groups.

Vrana further explained that since marijuana is still a controlled substance federally, conducting marijuana research is challenging. Therefore, placing the clinical trial under PA Options for Wellness protects the university.

The university is also partnering with a dispensary which would be responsible for dispensing the medical marijuana to the study participants.

Penn State is also researching cell cultures and animal studies to determine the dosage and various combinations of marijuana chemicals such as THC and CBD.

Drexel University and Agronomed Biologics LLC will be enrolling patients to determine the effects of marijuana consumption on several medical conditions and symptoms.

Lake Erie and CannTech PA will study how medical marijuana consumption can alter patients’ patterns of opioid use.

All this research is supposed to provide scientific evidence on the benefits of marijuana. Experts hope that the different studies will provide some clarification regarding the benefits that members of the cannabis industry, such as SinglePoint Inc. (OTCQB: SING), have believed to be possible benefits of marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

On Monday, marijuana reform advocates in Ohio filed a motion to put a marijuana legalization bill on the 2020 ballot for the voters to decide.

The measure, which is referred to as Regulate Marijuana Like Alcohol, would permit people aged 21 and above to purchase, possess, and cultivate marijuana for personal use. However, possession of cannabis would be limited at one ounce, and individuals would be allowed to cultivate a maximum of six plants, out of which three could be mature.

The petition to put marijuana legalization on the November ballot was filed with the state attorney general a week after it was reported for the first time. The office of the attorney general has ten days to certify the language.

The legislation stipulates that the regulation of the marijuana market and issuing of permits to marijuana businesses would be the responsibility of the Department of Commerce in Ohio.

The bill also authorizes the legislature to impose a special excise tax on all marijuana sales. Twenty-five percent of the tax proceeds would be allotted to the commission whose work is to promote social equity in the marijuana sector. Fifty-percent of the tax revenue would assigned to the State Local Government Fund, and ten percent would divided amongst the jurisdictions that allow marijuana businesses to operate.

During the 2020 elections, the voters would also decide whether through enactment of an ordinance, initiated or referred measure municipalities and towns within the state would be allowed to prohibit marijuana businesses from operating within their region.

The legislation also has a provision aimed at enhancing social equity where the Department of Commerce would be allowed to research to determine whether in the past there was discrimination when the department was issuing marijuana-related permits, as well as whether the effects of the war on drugs has prevented minorities from participating in the medical marijuana industry in Ohio.

In a press release, Tom Haren, the general counsel for the marijuana reform campaign, said that marijuana consumption should be allowed for adults.

For the petition to qualify for 2020, the advocates must gather about 443,000 signatures from registered voters within the state by July 1. The campaign for signature gathering will require extensive funding because of the vast size of Ohio and the fact that the initiative was launched late in the election year.

Since 2015, support for marijuana legalization has increased within Ohio.

The petition committee is comprised of a former NFL player, patients’ advocates, and a mental health specialist.

Anthony Riley, who is a member of the committee, said that for many years, people of color had been the primary targets for marijuana prohibition in Ohio as well as the sick, disabled, and the poor have been mistreated when they tried replacing opioid prescriptions with medical marijuana.

These activists now feel that voters should be given the chance to decide whether recreational marijuana should be legalized in the state or not. Industry watchers believe that cannabis companies like SinglePoint Inc. (OTCQB: SING) will be following events in Ohio closely to see whether the legalization advocates can pull off the signature gathering exercise in the limited time that they have left.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Diversified holding company SinglePoint’s (OTCQB: SING) 1606 Original Hemp Cigarette brand has been amassing substantial sales online. An article further discussing the company’s hemp brand reads, “On the hemp front, SinglePoint’s 1606 Original Hemp line features a filtered, pre-rolled, 100% tobacco- and nicotine-free hemp cigarette. Of note is that the smokable hemp market currently represents about 2% of the overall CBD market — with 250% growth from 2017 to 2018. New Frontier Data estimates that the U.S. legal cannabis market will grow to $30 billion by 2025 (http://cnw.fm/Dyg8E). Based on those numbers, SinglePoint is at the vanguard of this trend as the company positions itself to supply quality hemp products to a demanding consumer marketplace desiring innovative hemp products. . . . SinglePoint continues to focus on being a diverse enterprise with an extensive footprint. For investors, the company’s solar and hemp programs offer the potential for major ROI in two thriving industries. SING is delivering on its strategy of acquiring and working with key company management to build successful candidate companies.”

To view the full article, visit http://cnw.fm/ldO5A

About SinglePoint Inc.

Founded in 2011, SinglePoint invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multinational brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

Zelira Therapeutics has developed a medical marijuana insomnia product known as Thunderbird. Zelira Therapeutics was previously called Zelda Therapeutics (ASX: ZLD), and it changed its name after merging with the USA’s Ilera Therapeutics LLC late last year.

For the past few years, Zelda, currently known as Zelira Therapeutics, has been working on a marijuana product used for treating insomnia, ZLT-101. In 2017,  Zelda Therapeutics obtained approval to conduct clinical trials with patients who have chronic insomnia in Australia. At the time of the merger, Zelda Therapeutics was also studying the use of marijuana in treating conditions such as autism, cancer, and opioid reduction, and it will continue to do so under the new company.

Zelira Therapeutics has operations both in the U.S. and Australia, and this gives it a robust platform in the global medical marijuana market.

On Wednesday, Zelira Therapeutics announced that it had completed phase 1b/2a of the clinical trials of ZLT-101. The study findings reveal that 23 patients who had chronic insomnia and were treated using ZLT-101 demonstrated statistical improvement in the Insomnia Severity Index (ISI) scores when they were compared with those who used the placebo. Patients who used ZLT-101 showed high tolerance since no adverse effects were reported.

Although ZLT-101 was well tolerated, some patients said that they experienced the following side effects; dry mouth, which was preceded by dizziness, headache, and feeling unwell. Out of the 23 patients using ZLT-101, 17 reported having experienced these mild side effects. Four participants who were placed on the placebo also said that they experienced the same side effects.

Zelira Therapeutics said that all adverse events that were noted during the clinical trials were classified as mild, and 97.5% of the cases had resolved overnight or as soon as the patient woke up the following day or were resolved at the end of the clinical trial.

Zelira said that lack of severe or persistent mild adverse cases is encouraging, given those linked with other insomnia therapies.

Prof. Peter Eastwood, who was the Principal Investigator for the study, said that it was impressive for the ZLT-101 treatment to achieve a statistically significant improvement in ISI scores, given the relatively short two-week dosing window. Prof. Eastwood is also the director of the Centre for Sleep Science, which is based at the University of Western Australia.

Although the clinical trial findings won’t be published until the end of March 2020, the Chairman of Zelira Osagie Imasogie said that the company can now commercialize ZLT-101 across the globe this year.

Patients who have chronic insomnia have challenges sleeping or staying asleep. They do not feel refreshed even after adequate sleep, and they also suffer from impairment during their day-to-day activities for a minimum of four weeks.

It is widely expected that other marijuana industry players, such as SinglePoint Inc. (OTCQB: SING), are happy that these research findings are positive since they add to the increasing body of evidence proving the therapeutic effects of marijuana on various health conditions.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Two medical marijuana doctors are under investigation after Florida health officials filed a complained against them based on information obtained by undercover investigators posing as patients. A lawyer representing one of the doctors termed it as a trap.

The Department of Health in Florida filed both complaints on the same day in 2019, and are waiting for administrative law judges to take action. This is the first significant action taken by Florida against doctors prescribing marijuana to patients.

Tallahassee doctor, Joseph Dorn is one of the doctors being investigated.

The complaint stated that Dorn was the chief medical officer of Medical Marijuana Treatment Clinics of Florida between Feb. 2017 and Jan. 2018. During this period, Dorn issued 3,292 patients with medical marijuana, and each new patient had to pay $299 for the appointment.

Dorn is being accused of failing to conduct physical examinations of ‘Patient O.G’ and ‘Patient B.D,’ which violates medical marijuana laws.

According to the complaint, Dorn failed to do the following;

• Did not assess the patients’ medical histories,
• Did not diagnose the men with at least one qualifying medical condition
• Failed to determine if the use of medical marijuana by the patients would outweigh the potential health risks, and
• Did not review the patients’ controlled-drug prescription histories in the state’s database

Dorn is accused of making untrue and fraudulent representations in or related to medicine by recording false details in the men’s’ files to justify entering physician certifications for medical marijuana.

In November of 2017, Patient B.D saw Dorn and complained of muscle spasms and anxiety, but Dorn diagnosed him with post-traumatic stress disorder. Dorn asked the patient if he had been in any car accident, and the patient said he had eight years before the appointment but did not provide details about the severity of the accident. However, in his records, Don wrote that Patient B.D was suffering from PTSD because of trauma from the accident.

Patient O.G reported the second complaint against dorn, and his record shows that he was diagnosed with PTSD. Dorn went on to record a list of symptoms the patient was experiencing, but Patient O.G did not say that he had any symptoms.

Speaking to The News Service of Florida, Dorn’s Lawyer, Robert Beasley, said that the veterans’ group contacted him and stated that Florida health officials were going after doctors who used a PTSD diagnosis when prescribing medical marijuana. Many military veterans have PTSD.

Justin Davis, a Gainesville area doctor, was accused of violating state law by operating his office near the medical marijuana operator Trulieve’s office in Lady Lake. He was also accused of referring patients to Trulieve, as well as failing to determine if Patient K.G was pregnant. Patient K.G  was also an undercover agent.

Industry watchers believe that these compliants in Florida are going to be followed closely by the entire marijuana industry, including SinglePoint Inc. (OTCQB: SING), because it may have far-reaching repurcussions on the willingness of doctors to recommend medical marijuana to patients that can be helped.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. Among other highlights from this week’s program, SinglePoint CEO Greg Lambrecht reviewed the company’s revenue numbers, reiterating, from a recent press release, that its revenues were up 190% from last year. “Again, this company is definitely going in the right direction as far as revenues and profit,” Lambrecht said. “This year [2020], the sky’s the limit. I don’t want to predict anything right now, but we’re optimistic we can do over $10 million.”

To view the full press release, visit http://cnw.fm/Nxq6k

About SinglePoint, Inc.

Founded in 2011 SinglePoint, Inc. invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

SinglePoint (OTCQB: SING) this morning reported preliminary, unaudited 2019 annual results. Among other highlights from the update, the company reportedly achieved more than $3,300,000 in revenue for 2019, representing an increase of 190% from 2018. In roughly six months of operation, $2,000,000 in revenue was derived directly from the company’s solar division, Direct Solar of America. Moving forward, SING plans to focus on Direct Solar and the company’s proprietary brand of smokable hemp, 1606 Original Hemp. “I am confident that our business units will continue to grow which translates to SinglePoint being in a better position than we have ever been. We believe the successful operating results in 2019 will continue into 2020 driving our value past historical values to new heights,” SinglePoint CEO Greg Lambrecht stated in the news release. “In my opinion, it’s never been a better time to be a shareholder of SinglePoint; we have growing business units in thriving sectors, we have recently become a fully reporting public company and are committed to continuing to enhance shareholder liquidity by uplisting to the appropriate exchange that allows investors to confidently invest in the company due to its trading volume.”

To view the full press release, visit http://cnw.fm/SAn8N

About SinglePoint, Inc.

Founded in 2011 SinglePoint, Inc. invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. Among other highlights from this week’s program, SinglePoint CEO Greg Lambrecht discussed the company’s ideal position to profit from its hemp cigarette brand as the price of hemp flower has decreased. “The price of hemp flower has really gone down. There’s been so many farmers that have started to grow hemp. So, it really has turned to our advantage,” SinglePoint CEO Greg Lambrecht stated in the interview. “It’s a perfect scenario for us, because the price has almost gone down by half, if not more. That means more margins for us, so we’re really excited about that.”

To view the full press release, visit http://cnw.fm/wFfQ2

About SinglePoint, Inc.

Founded in 2011 SinglePoint, Inc. invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.